Pacific Biosciences of California Inc (PACB)
1.775
+0.06
(+3.20%)
USD |
NASDAQ |
May 10, 16:00
1.775
0.00 (0.00%)
After-Hours: 18:11
Pacific Biosciences of California Free Cash Flow (Quarterly): -59.58M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -59.58M |
| September 30, 2023 | -66.01M |
| June 30, 2023 | -44.01M |
| March 31, 2023 | -98.41M |
| December 31, 2022 | -65.65M |
| September 30, 2022 | -67.24M |
| June 30, 2022 | -64.58M |
| March 31, 2022 | -82.67M |
| December 31, 2021 | -34.55M |
| September 30, 2021 | -41.78M |
| June 30, 2021 | -17.28M |
| March 31, 2021 | -23.50M |
| December 31, 2020 | -14.33M |
| September 30, 2020 | -18.34M |
| June 30, 2020 | -24.11M |
| March 31, 2020 | 75.25M |
| December 31, 2019 | -18.32M |
| September 30, 2019 | -18.09M |
| June 30, 2019 | -18.17M |
| March 31, 2019 | -26.57M |
| December 31, 2018 | -19.04M |
| September 30, 2018 | -14.27M |
| June 30, 2018 | -15.85M |
| March 31, 2018 | -19.12M |
| December 31, 2017 | -21.26M |
| Date | Value |
|---|---|
| September 30, 2017 | -21.10M |
| June 30, 2017 | -16.26M |
| March 31, 2017 | -19.34M |
| December 31, 2016 | -15.55M |
| September 30, 2016 | -18.18M |
| June 30, 2016 | -21.68M |
| March 31, 2016 | -20.72M |
| December 31, 2015 | -1.592M |
| September 30, 2015 | -16.23M |
| June 30, 2015 | -8.449M |
| March 31, 2015 | -24.63M |
| December 31, 2014 | -15.83M |
| September 30, 2014 | -6.425M |
| June 30, 2014 | -14.08M |
| March 31, 2014 | -16.73M |
| December 31, 2013 | -14.68M |
| September 30, 2013 | 18.49M |
| June 30, 2013 | -16.69M |
| March 31, 2013 | -17.87M |
| December 31, 2012 | -18.66M |
| September 30, 2012 | -18.13M |
| June 30, 2012 | -24.12M |
| March 31, 2012 | -17.61M |
| December 31, 2011 | -16.21M |
| September 30, 2011 | -26.11M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-98.41M
Minimum
Mar 2023
75.25M
Maximum
Mar 2020
-36.92M
Average
-34.55M
Median
Dec 2021
Free Cash Flow (Quarterly) Benchmarks
| AtriCure Inc | -23.79M |
| BioSig Technologies Inc | -2.946M |
| Intellia Therapeutics Inc | -94.57M |
| Shockwave Medical Inc | 27.45M |
| Outset Medical Inc | -25.50M |